نتائج البحث 981-990 من 14252 لعملية البحث عن treatment resistant depression
... treating patients with B-cell non-Hodgkin lymphoma that has returned (recurrent) or did not respond to treatment (refractory). Monoclonal antibodies, such ...
The purpose of this study is to compare the effects on low-risk breast cancer receiving usual care that includes regional radiation therapy, with receiving ...
Inotuzumab Ozogamicin In Treating Younger Patients With Relapsed Or Refractory CD22 Positive B Acute Lymphoblastic Leukemia. Rochester, Minn. This phase II ...
... Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment. Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The ...
Medication management, Pediatric psychiatric hospitalization, Complex care coordination, Depression, Bipolar disorder, ...Suicidal behavior, Attention ...
Also want to find out if kidney tumor treatment leads to an improvement in these immune markers. ... A Registry for Children Treated with Proton Radiation Therapy.
This phase II trials studies how well acalabrutinib with or without obinutuzumab works in treating participants with early-stage chronic lymphocytic ...
Epilepsy & Seizures Discussions. Chris Gautier, Volunteer Mentor · New approach to Treating Drug-Resistant Epilepsy. 48 Replies Tue, Apr 07, 2026. sophiasmith01.
A Study to Evaluate VSV-hIFNbeta-NIS to Treat Patients with Relapsed/Refractory Multiple Myleoma, Acute Myeloid Leukemia, or T-cell Lymphoma. Rochester, Minn., ...
Giving venetoclax with ibrutinib and rituximab with may work better in treating patients with previously untreated Waldenstrom's macroglobulinemia than ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.